
Welcome
Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd
Tianyuan pharmaceutical company in Zhangjiang Eastern has built 500 square meters of pilot laboratories, equipped with two sets of 50L glass reactor, four sets of 100L double reactor, six sets of 50L rotary evaporator and matching heating and cooling equipment, to complete the 10kg Pilot complex experiments in complex compounds in Jiaozhou, Qingdao, a steady cooperation of the amplification plant, from 100kg to the tonnage of the enlarged production.
Our Main Produts
Intermediate

Welcome To Tianyuan Pharmaceutical
Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd. is a manufacturer specializing in targeted anticancer drug research and is devoted to researching, manufacturing and marketing medical raw materials. The company’s main products are crizotinib, afatinib, Capmatinib, Aloitinib, Sorafenib, Ibrutinib, Laurodeinib and many other kinds of TINI API and intermedaites.
Melanotan: Understanding Its Uses, Benefits, and Risks
Melanotan is a synthetic peptide developed to mimic the action of alpha-melanocyte-stimulating hormone (α-MSH), a natural hormone that regulates skin pigmentation. It has gained popularity for its ability to promote tanning without prolonged sun exposure, making it appealing to individuals seeking a darker skin tone with reduced risk of UV damage. However, its use remains…
Tirzepatide 2023788-19-2: Best in Metabolic and Diabetes Treatment
The pharmaceutical sector has witnessed tremendous innovation in the creation of cutting-edge treatments for obesity and diabetes in recent years. Tirzepatide 2023788-19-2, a next-generation peptide medication that is revolutionising the treatment of metabolic illnesses, is one substance that has attracted significant attention on a global scale. Tirzepatide has emerged as one of the most talked-about…
All You Need to Know About Retatrutide 2381089-83-2
In the realm of contemporary medicine and pharmaceutical innovation, novel substances are continuously investigated for their possible application in the treatment of diabetes, obesity, and other metabolic disorders. Retatrutide 2381089-83-2 is one such substance that has recently drawn interest. Because of its promising research background and potential future significance in the development of metabolic treatments,…
